866-997-4948(US-Canada Toll Free)

Global Parkinsons Disease Drug Market Research Report 2020

Published By :

QYResearch

Published Date : Feb 2020

Category :

Pharmaceutical

No. of Pages : 121 Pages

This report focuses on Parkinson's Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old


Table of Contents

1 Parkinson's Disease Drug Market Overview
1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Parkinson's Disease Drug Segment by Type
1.2.1 Global Parkinson's Disease Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Parkinson's Disease Drug Segment by Application
1.3.1 Parkinson's Disease Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson's Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Parkinson's Disease Drug Revenue 2015-2026
1.4.2 Global Parkinson's Disease Drug Sales 2015-2026
1.4.3 Parkinson's Disease Drug Market Size by Region: 2020 Versus 2026

2 Global Parkinson's Disease Drug Market Competition by Manufacturers
2.1 Global Parkinson's Disease Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Parkinson's Disease Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Parkinson's Disease Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Parkinson's Disease Drug Manufacturing Sites, Area Served, Product Type
2.5 Parkinson's Disease Drug Market Competitive Situation and Trends
2.5.1 Parkinson's Disease Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Parkinson's Disease Drug Players (Opinion Leaders)

3 Parkinson's Disease Drug Retrospective Market Scenario by Region
3.1 Global Parkinson's Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Parkinson's Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Parkinson's Disease Drug Market Facts & Figures by Country
3.3.1 North America Parkinson's Disease Drug Sales by Country
3.3.2 North America Parkinson's Disease Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Parkinson's Disease Drug Market Facts & Figures by Country
3.4.1 Europe Parkinson's Disease Drug Sales by Country
3.4.2 Europe Parkinson's Disease Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parkinson's Disease Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Parkinson's Disease Drug Sales by Region
3.5.2 Asia Pacific Parkinson's Disease Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parkinson's Disease Drug Market Facts & Figures by Country
3.6.1 Latin America Parkinson's Disease Drug Sales by Country
3.6.2 Latin America Parkinson's Disease Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Parkinson's Disease Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Parkinson's Disease Drug Sales by Country
3.7.2 Middle East and Africa Parkinson's Disease Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Parkinson's Disease Drug Historic Market Analysis by Type
4.1 Global Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
4.2 Global Parkinson's Disease Drug Revenue Market Share by Type (2015-2020)
4.3 Global Parkinson's Disease Drug Price Market Share by Type (2015-2020)
4.4 Global Parkinson's Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Parkinson's Disease Drug Historic Market Analysis by Application
5.1 Global Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
5.2 Global Parkinson's Disease Drug Revenue Market Share by Application (2015-2020)
5.3 Global Parkinson's Disease Drug Price by Application (2015-2020)

6 Company Profiles and Key Figures in Parkinson's Disease Drug Business
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Akorn
6.2.1 Akorn Parkinson's Disease Drug Production Sites and Area Served
6.2.2 Akorn Description, Business Overview and Total Revenue
6.2.3 Akorn Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Akorn Products Offered
6.2.5 Akorn Recent Development
6.3 GSK
6.3.1 GSK Parkinson's Disease Drug Production Sites and Area Served
6.3.2 GSK Description, Business Overview and Total Revenue
6.3.3 GSK Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GSK Products Offered
6.3.5 GSK Recent Development
6.4 Novartis
6.4.1 Novartis Parkinson's Disease Drug Production Sites and Area Served
6.4.2 Novartis Description, Business Overview and Total Revenue
6.4.3 Novartis Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.4.5 Novartis Recent Development
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Parkinson's Disease Drug Production Sites and Area Served
6.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.5.3 Boehringer Ingelheim Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Boehringer Ingelheim Products Offered
6.5.5 Boehringer Ingelheim Recent Development
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Parkinson's Disease Drug Production Sites and Area Served
6.6.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Teva Pharmaceutical Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Teva Pharmaceutical Products Offered
6.6.5 Teva Pharmaceutical Recent Development
6.7 Abbvie
6.6.1 Abbvie Parkinson's Disease Drug Production Sites and Area Served
6.6.2 Abbvie Description, Business Overview and Total Revenue
6.6.3 Abbvie Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Abbvie Products Offered
6.7.5 Abbvie Recent Development
6.8 Kyowa Hakko Kirin Pharma
6.8.1 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Sites and Area Served
6.8.2 Kyowa Hakko Kirin Pharma Description, Business Overview and Total Revenue
6.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Kyowa Hakko Kirin Pharma Products Offered
6.8.5 Kyowa Hakko Kirin Pharma Recent Development
6.9 Astellas Pharma
6.9.1 Astellas Pharma Parkinson's Disease Drug Production Sites and Area Served
6.9.2 Astellas Pharma Description, Business Overview and Total Revenue
6.9.3 Astellas Pharma Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Astellas Pharma Products Offered
6.9.5 Astellas Pharma Recent Development
6.10 Desitin Arzneimittel
6.10.1 Desitin Arzneimittel Parkinson's Disease Drug Production Sites and Area Served
6.10.2 Desitin Arzneimittel Description, Business Overview and Total Revenue
6.10.3 Desitin Arzneimittel Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Desitin Arzneimittel Products Offered
6.10.5 Desitin Arzneimittel Recent Development
6.11 Endo Pharmaceuticals
6.11.1 Endo Pharmaceuticals Parkinson's Disease Drug Production Sites and Area Served
6.11.2 Endo Pharmaceuticals Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.11.3 Endo Pharmaceuticals Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Endo Pharmaceuticals Products Offered
6.11.5 Endo Pharmaceuticals Recent Development
6.12 F.Hoffmann-La Roche
6.12.1 F.Hoffmann-La Roche Parkinson's Disease Drug Production Sites and Area Served
6.12.2 F.Hoffmann-La Roche Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.12.3 F.Hoffmann-La Roche Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 F.Hoffmann-La Roche Products Offered
6.12.5 F.Hoffmann-La Roche Recent Development
6.13 H.Lundbeck
6.13.1 H.Lundbeck Parkinson's Disease Drug Production Sites and Area Served
6.13.2 H.Lundbeck Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.13.3 H.Lundbeck Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 H.Lundbeck Products Offered
6.13.5 H.Lundbeck Recent Development
6.14 Valeant
6.14.1 Valeant Parkinson's Disease Drug Production Sites and Area Served
6.14.2 Valeant Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.14.3 Valeant Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Valeant Products Offered
6.14.5 Valeant Recent Development
6.15 Apokyn
6.15.1 Apokyn Parkinson's Disease Drug Production Sites and Area Served
6.15.2 Apokyn Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.15.3 Apokyn Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Apokyn Products Offered
6.15.5 Apokyn Recent Development
6.16 Orion
6.16.1 Orion Parkinson's Disease Drug Production Sites and Area Served
6.16.2 Orion Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.16.3 Orion Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Orion Products Offered
6.16.5 Orion Recent Development
6.17 Stada Arzneimittel
6.17.1 Stada Arzneimittel Parkinson's Disease Drug Production Sites and Area Served
6.17.2 Stada Arzneimittel Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.17.3 Stada Arzneimittel Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Stada Arzneimittel Products Offered
6.17.5 Stada Arzneimittel Recent Development
6.18 US WorldMeds
6.18.1 US WorldMeds Parkinson's Disease Drug Production Sites and Area Served
6.18.2 US WorldMeds Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.18.3 US WorldMeds Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.18.4 US WorldMeds Products Offered
6.18.5 US WorldMeds Recent Development
6.19 Bausch Health
6.19.1 Bausch Health Parkinson's Disease Drug Production Sites and Area Served
6.19.2 Bausch Health Parkinson's Disease Drug Description, Business Overview and Total Revenue
6.19.3 Bausch Health Parkinson's Disease Drug Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Bausch Health Products Offered
6.19.5 Bausch Health Recent Development

7 Parkinson's Disease Drug Manufacturing Cost Analysis
7.1 Parkinson's Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parkinson's Disease Drug
7.4 Parkinson's Disease Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parkinson's Disease Drug Distributors List
8.3 Parkinson's Disease Drug Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Parkinson's Disease Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parkinson's Disease Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Parkinson's Disease Drug by Type (2021-2026)
10.2 Parkinson's Disease Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parkinson's Disease Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Parkinson's Disease Drug by Application (2021-2026)
10.3 Parkinson's Disease Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parkinson's Disease Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Parkinson's Disease Drug by Region (2021-2026)
10.4 North America Parkinson's Disease Drug Estimates and Projections (2021-2026)
10.5 Europe Parkinson's Disease Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Parkinson's Disease Drug Estimates and Projections (2021-2026)
10.7 Latin America Parkinson's Disease Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Parkinson's Disease Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Table

List of Tables
Table 1. Global Parkinson's Disease Drug Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Parkinson's Disease Drug Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Parkinson's Disease Drug Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Parkinson's Disease Drug Manufacturers Covered in This Study
Table 5. Global Parkinson's Disease Drug Sales (K Doses) by Manufacturers (2015-2020)
Table 6. Global Parkinson's Disease Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Parkinson's Disease Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Parkinson's Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Parkinson's Disease Drug Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Parkinson's Disease Drug Sales Sites and Area Served
Table 11. Manufacturers Parkinson's Disease Drug Product Types
Table 12. Global Parkinson's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Parkinson's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Parkinson's Disease Drug Players
Table 16. Global Parkinson's Disease Drug Sales (K Doses) by Region (2015-2020)
Table 17. Global Parkinson's Disease Drug Sales Market Share by Region (2015-2020)
Table 18. Global Parkinson's Disease Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Parkinson's Disease Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 21. North America Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 22. North America Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 25. Europe Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Parkinson's Disease Drug Sales by Region (2015-2020) (K Doses)
Table 29. Asia Pacific Parkinson's Disease Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Parkinson's Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Parkinson's Disease Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 33. Latin America Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 37. Middle East and Africa Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Parkinson's Disease Drug Sales (K Doses) by Type (2015-2020)
Table 41. Global Parkinson's Disease Drug Sales Share by Type (2015-2020)
Table 42. Global Parkinson's Disease Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Parkinson's Disease Drug Revenue Share by Type (2015-2020)
Table 44. Global Parkinson's Disease Drug Price (USD/Dose) by Type (2015-2020)
Table 45. Global Parkinson's Disease Drug Sales (K Doses) by Application (2015-2020)
Table 46. Global Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Table 47. Global Parkinson's Disease Drug Sales Growth Rate by Application (2015-2020)
Table 48. Merck Parkinson's Disease Drug Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Merck Main Product
Table 52. Merck Recent Development
Table 53. Akorn Parkinson's Disease Drug Corporation Information
Table 54. Akorn Corporation Information
Table 55. Akorn Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Akorn Main Product
Table 57. Akorn Recent Development
Table 58. GSK Parkinson's Disease Drug Corporation Information
Table 59. GSK Corporation Information
Table 60. GSK Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. GSK Main Product
Table 62. GSK Recent Development
Table 63. Novartis Parkinson's Disease Drug Corporation Information
Table 64. Novartis Corporation Information
Table 65. Novartis Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 66. Novartis Main Product
Table 67. Novartis Recent Development
Table 68. Boehringer Ingelheim Parkinson's Disease Drug Corporation Information
Table 69. Boehringer Ingelheim Corporation Information
Table 70. Boehringer Ingelheim Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 71. Boehringer Ingelheim Main Product
Table 72. Boehringer Ingelheim Recent Development
Table 73. Teva Pharmaceutical Parkinson's Disease Drug Corporation Information
Table 74. Teva Pharmaceutical Corporation Information
Table 75. Teva Pharmaceutical Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 76. Teva Pharmaceutical Main Product
Table 77. Teva Pharmaceutical Recent Development
Table 78. Abbvie Parkinson's Disease Drug Corporation Information
Table 79. Abbvie Corporation Information
Table 80. Abbvie Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. Abbvie Main Product
Table 82. Abbvie Recent Development
Table 83. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Corporation Information
Table 84. Kyowa Hakko Kirin Pharma Corporation Information
Table 85. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. Kyowa Hakko Kirin Pharma Main Product
Table 87. Kyowa Hakko Kirin Pharma Recent Development
Table 88. Astellas Pharma Parkinson's Disease Drug Corporation Information
Table 89. Astellas Pharma Corporation Information
Table 90. Astellas Pharma Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 91. Astellas Pharma Main Product
Table 92. Astellas Pharma Recent Development
Table 93. Desitin Arzneimittel Parkinson's Disease Drug Corporation Information
Table 94. Desitin Arzneimittel Corporation Information
Table 95. Desitin Arzneimittel Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 96. Desitin Arzneimittel Main Product
Table 97. Desitin Arzneimittel Recent Development
Table 98. Endo Pharmaceuticals Parkinson's Disease Drug Corporation Information
Table 99. Endo Pharmaceuticals Corporation Information
Table 100. Endo Pharmaceuticals Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 101. Endo Pharmaceuticals Main Product
Table 102. Endo Pharmaceuticals Recent Development
Table 103. F.Hoffmann-La Roche Parkinson's Disease Drug Corporation Information
Table 104. F.Hoffmann-La Roche Corporation Information
Table 105. F.Hoffmann-La Roche Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 106. F.Hoffmann-La Roche Main Product
Table 107. F.Hoffmann-La Roche Recent Development
Table 108. H.Lundbeck Parkinson's Disease Drug Corporation Information
Table 109. H.Lundbeck Corporation Information
Table 110. H.Lundbeck Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 111. H.Lundbeck Main Product
Table 112. H.Lundbeck Recent Development
Table 113. Valeant Parkinson's Disease Drug Corporation Information
Table 114. Valeant Corporation Information
Table 115. Valeant Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. Valeant Main Product
Table 117. Valeant Recent Development
Table 118. Apokyn Parkinson's Disease Drug Corporation Information
Table 119. Apokyn Corporation Information
Table 120. Apokyn Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 121. Apokyn Main Product
Table 122. Apokyn Recent Development
Table 123. Orion Parkinson's Disease Drug Corporation Information
Table 124. Orion Corporation Information
Table 125. Orion Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 126. Orion Main Product
Table 127. Orion Recent Development
Table 128. Stada Arzneimittel Parkinson's Disease Drug Corporation Information
Table 129. Stada Arzneimittel Corporation Information
Table 130. Stada Arzneimittel Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 131. Stada Arzneimittel Main Product
Table 132. Stada Arzneimittel Recent Development
Table 133. US WorldMeds Parkinson's Disease Drug Corporation Information
Table 134. US WorldMeds Corporation Information
Table 135. US WorldMeds Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 136. US WorldMeds Main Product
Table 137. US WorldMeds Recent Development
Table 138. Bausch Health Parkinson's Disease Drug Corporation Information
Table 139. Bausch Health Corporation Information
Table 140. Bausch Health Parkinson's Disease Drug Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 141. Bausch Health Main Product
Table 142. Bausch Health Recent Development
Table 143. Sales Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Parkinson's Disease Drug Distributors List
Table 146. Parkinson's Disease Drug Customers List
Table 147. Market Key Trends
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Global Parkinson's Disease Drug Sales (K Doses) Forecast by Type (2021-2026)
Table 151. Global Parkinson's Disease Drug Sales Market Share Forecast by Type (2021-2026)
Table 152. Global Parkinson's Disease Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 153. Global Parkinson's Disease Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 154. Global Parkinson's Disease Drug Sales (K Doses) Forecast by Application (2021-2026)
Table 155. Global Parkinson's Disease Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 156. Global Parkinson's Disease Drug Sales (K Doses) Forecast by Region (2021-2026)
Table 157. Global Parkinson's Disease Drug Sales Market Share Forecast by Region (2021-2026)
Table 158. Global Parkinson's Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Global Parkinson's Disease Drug Revenue Market Share Forecast by Region (2021-2026)
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Parkinson's Disease Drug
Figure 2. Global Parkinson's Disease Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Sinemet-CR Product Picture
Figure 4. Trastal Product Picture
Figure 5. Madopar Product Picture
Figure 6. COMT Inhibitor Product Picture
Figure 7. Other Product Picture
Figure 8. Global Parkinson's Disease Drug Consumption Market Share by Application: 2020 VS 2026
Figure 9. Under 40 Years Old
Figure 10. 40-65 Years Old
Figure 11. Above 65 Years Old
Figure 12. Global Parkinson's Disease Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Parkinson's Disease Drug Sales Capacity (K Doses) (2015-2026)
Figure 14. Global Parkinson's Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Parkinson's Disease Drug Sales Share by Manufacturers in 2020
Figure 16. Global Parkinson's Disease Drug Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease Drug Revenue in 2019
Figure 18. Parkinson's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Parkinson's Disease Drug Sales Market Share by Region (2015-2020)
Figure 20. Global Parkinson's Disease Drug Sales Market Share by Region in 2019
Figure 21. Global Parkinson's Disease Drug Revenue Market Share by Region (2015-2020)
Figure 22. Global Parkinson's Disease Drug Revenue Market Share by Region in 2019
Figure 23. North America Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 24. North America Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 25. U.S. Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 26. U.S. Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 28. Canada Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 30. Europe Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 31. Germany Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 32. Germany Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 34. France Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 36. U.K. Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Italy Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 40. Russia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Parkinson's Disease Drug Sales Market Share by Region in 2019
Figure 42. Asia Pacific Parkinson's Disease Drug Revenue Market Share by Region in 2019
Figure 43. China Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 44. China Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 46. Japan Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 48. South Korea Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 50. India Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Australia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 54. Taiwan Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 56. Indonesia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 58. Thailand Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 60. Malaysia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 62. Philippines Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 64. Vietnam Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 66. Latin America Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 67. Mexico Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 68. Mexico Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Brazil Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Argentina Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 75. Turkey Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Turkey Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Saudi Arabia Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 80. U.A.E Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Parkinson's Disease Drug by Type (2015-2020)
Figure 82. Sales Market Share of Parkinson's Disease Drug by Type in 2019
Figure 83. Revenue Share of Parkinson's Disease Drug by Type (2015-2020)
Figure 84. Revenue Market Share of Parkinson's Disease Drug by Type in 2019
Figure 85. Global Parkinson's Disease Drug Sales Growth by Type (2015-2020) (K Doses)
Figure 86. Global Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Figure 87. Global Parkinson's Disease Drug Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Parkinson's Disease Drug by Application (2015-2020)
Figure 89. Global Revenue Share of Parkinson's Disease Drug by Application in 2020
Figure 90. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Kyowa Hakko Kirin Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Desitin Arzneimittel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. F.Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. H.Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Apokyn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Orion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Stada Arzneimittel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. US WorldMeds Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Price Trend of Key Raw Materials
Figure 110. Manufacturing Cost Structure of Parkinson's Disease Drug
Figure 111. Manufacturing Process Analysis of Parkinson's Disease Drug
Figure 112. Parkinson's Disease Drug Industrial Chain Analysis
Figure 113. Channels of Distribution
Figure 114. Distributors Profiles
Figure 115. Porter's Five Forces Analysis
Figure 116. North America Parkinson's Disease Drug Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 117. North America Parkinson's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Europe Parkinson's Disease Drug Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 119. Europe Parkinson's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Latin America Parkinson's Disease Drug Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 121. Latin America Parkinson's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Middle East and Africa Parkinson's Disease Drug Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 123. Middle East and Africa Parkinson's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 124. Asia Pacific Parkinson's Disease Drug Sales (K Doses) and Growth Rate Forecast (2021-2026)
Figure 125. Asia Pacific Parkinson's Disease Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *